January 2012 Affectis Granted Patent for AFC-5128, other P2X7 Antagonists Boehringer Ingelheim Prolongates Drug Discovery Collaboration with Priaxon NovAliX Enters into Multi-Target Integrated Drug Discovery Collaboration with Teijin Pharma
January 2012
Affectis Granted Patent for AFC-5128, other P2X7 Antagonists
Boehringer Ingelheim Prolongates Drug Discovery Collaboration with Priaxon
NovAliX Enters into Multi-Target Integrated Drug Discovery Collaboration with Teijin Pharma
About Life Sciences Industry News Subscribe Advertise Contribute
